Skip to content
10-Q

Quarterly Report

CONTEXT THERAPEUTICS INC. CNTX

0001842952-25-000081

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 89.7M sh
Shares Diluted Q2 2025 · Jun 30, 2025 95.19M sh
Shares Diluted Q2 2025 · Jun 30, 2025 95.19M sh
Shares Diluted Q2 2025 · Jun 30, 2024 54.96M sh
Shares Diluted Q2 2025 · Jun 30, 2024 35.46M sh
Capex Q2 2025 · Jun 30, 2025 $33.95K
Capex Q2 2025 · Jun 30, 2024 $0
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$10.86M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$7.72M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $83.52M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $94.43M
Stockholders Equity Q2 2025 · Jun 30, 2025 $82.54M
Stockholders Equity Q2 2025 · Mar 31, 2025 $90.98M
Stockholders Equity Q2 2025 · Dec 31, 2024 $95.27M
Stockholders Equity Q2 2025 · Jun 30, 2024 $101.1M
Stockholders Equity Q2 2025 · Mar 31, 2024 $8.44M
Stockholders Equity Q2 2025 · Dec 31, 2023 $11.87M
Current Liabilities Q2 2025 · Jun 30, 2025 $4.56M
Current Liabilities Q2 2025 · Dec 31, 2024 $2.75M
Total Liabilities Q2 2025 · Jun 30, 2025 $4.61M
Total Liabilities Q2 2025 · Dec 31, 2024 $2.86M
Current Assets Q2 2025 · Jun 30, 2025 $86.95M
Current Assets Q2 2025 · Dec 31, 2024 $97.9M
Total Assets Q2 2025 · Jun 30, 2025 $87.15M
Total Assets Q2 2025 · Dec 31, 2024 $98.13M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.09
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.14
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.04
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.17
Eps Basic Q2 2025 · Jun 30, 2025 −$0.09
Eps Basic Q2 2025 · Jun 30, 2025 −$0.14
Eps Basic Q2 2025 · Jun 30, 2024 −$0.04
Eps Basic Q2 2025 · Jun 30, 2024 −$0.17
Sga Expense Q2 2025 · Jun 30, 2025 $1.93M
Sga Expense Q2 2025 · Jun 30, 2025 $3.99M
Sga Expense Q2 2025 · Jun 30, 2024 $1.7M
Sga Expense Q2 2025 · Jun 30, 2024 $3.55M
Net Income Q2 2025 · Jun 30, 2025 −$8.83M
Net Income Q2 2025 · Jun 30, 2025 −$13.4M
Net Income Q2 2025 · Mar 31, 2025 −$4.58M
Net Income Q2 2025 · Jun 30, 2024 −$2.25M
Net Income Q2 2025 · Jun 30, 2024 −$5.92M
Net Income Q2 2025 · Mar 31, 2024 −$3.67M
Operating Income Q2 2025 · Jun 30, 2025 −$9.76M
Operating Income Q2 2025 · Jun 30, 2025 −$15.29M
Operating Income Q2 2025 · Jun 30, 2024 −$3.09M
Operating Income Q2 2025 · Jun 30, 2024 −$6.91M